“…Pre-processing of spectral data allows for spectral correction by increasing the signal and minimizing undesired information including baseline drifts, scatter variation, path-length variation, and background noise. The most common pretreatment techniques (Table 1) used in pharmaceutical data processing include multiplicative scatter correction (MSC) (Virtanen et al, 2008;Lee et al, 2009;Cairos et al, 2009;Puchert et al 2010;Neves et al, 2010), standard normal variate (SNV) (Virtanen et al, 2008;Cairos et al, 2009;Cruz et al, 2011), and Savitzky-Golay filtering (Virtanen Palou et al (2012) et al , 2008;Cairos et al, 2009;Puchert et al, 2010;Gendre et al, 2011;Corredor et al, 2011;Cruz et al, 2011;Neves et al, 2012). Briefly, the purpose of MSC is to correct the scatter level of the spectra by elimination of the spectral difference of the data (Puchert et al, 2010).…”